Cellulose acetate-based polymer electrolyte for energy storage application with the influence of BaTiO nanofillers on the electrochemical properties: A progression in biopolymer-EDLC technology.

The bio-based solid polymer electrolyte serves as a promising choice for the next generation of energy storage devices to meet the requirement of green chemistry. In the current research, a green plasticized magnesium ion-conducting biopolymer electrolyte was developed using simple solution casting method for Electric Double Layer Capacitors (EDLC) applications. The biopolymer Cellulose Acetate (CA) as the host polymer, with varying concentrations of BaTiO as the nanofiller, Mg(CFSO) as the ionic dopant, and PEG as the plasticizer.

Synthesis and analysis of multifunctional graphene oxide/AgO-PVA/chitosan hybrid polymeric composite for wound healing applications.

The requirement for accurate treatments for skin diseases and wounds, generated a rising interest towards multifunctional polymer composites, that are capable of mimicking the natural compositions in human body. Also, electroactive composite films disseminate endogenous electrical stimulations that encourage cell migration and its proliferation at wound site, proposing greater opportunities in upgrading the conventional wound patches. In this work, the composite film made of graphene oxide, AgO, PVA and chitosan were developed for wound healing applications, by the solution casting method.

Plumbagin induces reactive oxygen species, which mediate apoptosis in human cervical cancer cells.

There is an emerging evidence that plumbagin (5-hydroxy-2-methyl-1, 4-naphthoquinone) may have potential as a chemotherapeutic agent. However, the growth inhibitory mechanisms of plumbagin have remained unexplored. The aim of the study was to determine whether plumbagin-induced cell death in human cervical cancer cell line, ME-180, exhibited biochemical characteristics of apoptosis and to check whether N-acetyl-l-cysteine (NAC), which is a free radical scavenger, can reverse the cytotoxic effects of plumbagin.

Antisense blocking of BRCA1 enhances sensitivity to plumbagin but not tamoxifen in BG-1 ovarian cancer cells.

Previous studies have shown that reduction in BRCA1 mRNA and protein can result in increased proliferation of BG-1 ovarian cancer cells in both in vitro and in vivo conditions, suggesting that BRCA1 may normally act as a growth inhibitor in these cells. Also, there are other reports that suggest that wild-type BRCA1 protein may repress estrogen receptor (ER) function either directly or indirectly. However, response to antiestrogen drugs in BRCA1-blocked ER-positive ovarian cancer cells has not been reported, and this served as the rationale for this study.